Tg Therapeutics (TGTX) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $390.9 million.
- Tg Therapeutics' Profit After Tax rose 997461.34% to $390.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $447.5 million, marking a year-over-year increase of 321523.95%. This contributed to the annual value of $23.4 million for FY2024, which is 8452.49% up from last year.
- As of Q3 2025, Tg Therapeutics' Profit After Tax stood at $390.9 million, which was up 997461.34% from $28.2 million recorded in Q2 2025.
- Tg Therapeutics' 5-year Profit After Tax high stood at $390.9 million for Q3 2025, and its period low was -$93.3 million during Q4 2021.
- Moreover, its 5-year median value for Profit After Tax was -$35.8 million (2022), whereas its average is -$5.9 million.
- Per our database at Business Quant, Tg Therapeutics' Profit After Tax tumbled by 9659.44% in 2024 and then soared by 997461.34% in 2025.
- Over the past 5 years, Tg Therapeutics' Profit After Tax (Quarter) stood at -$93.3 million in 2021, then grew by 15.93% to -$78.5 million in 2022, then skyrocketed by 81.63% to -$14.4 million in 2023, then skyrocketed by 261.84% to $23.3 million in 2024, then skyrocketed by 1575.43% to $390.9 million in 2025.
- Its Profit After Tax was $390.9 million in Q3 2025, compared to $28.2 million in Q2 2025 and $5.1 million in Q1 2025.